NDAORALTABLET
Approved
Jun 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6
Data completeness
3/8 — Basic
TAGAMET HB (cimetidine) by Teva is histamine h2 receptor antagonists [moa]. First approved in 1995.
Drug data last refreshed 10h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TAGAMET HB (cimetidine) is an oral histamine H2-receptor antagonist used to reduce stomach acid production and treat acid-related gastrointestinal conditions. It works by blocking H2 receptors on gastric parietal cells, decreasing acid secretion and providing symptomatic relief. This is an over-the-counter formulation for heartburn and acid indigestion in the general population.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), roles on this mature asset are typically smaller support teams focused on maintaining market position rather than growth initiatives.
Mechanism of Action
Histamine H2 Receptor Antagonists
Pharmacologic Class:
Histamine-2 Receptor Antagonist
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (6)
Effect of Cimetidine on the PK of Imeglimin
Started Jun 2018
16 enrolled
Healthy
Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects
Started Jan 2018
14 enrolled
Healthy Subjects
Drug-drug Interaction Study of CHF5993 With Cimetidine
Started May 2014
25 enrolled
COPD
Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body
Started Jan 2009
12 enrolled
Generalized Anxiety Disorder
Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX
Started Jan 2007
18 enrolled
Healthy Adult Subjects
Worked on TAGAMET HB at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.